Article
An engineered IdeS variant with enhanced activity and performance for IgG degradation
2026-07-01
Abstract excerpt
IgG-degrading enzymes have emerged as innovative therapeutic agents for treating conditions driven by pathogenic antibodies. Here, we used structure-guided rational design to engineer IdeS M33 , a double mutant (K167R/D226E) of the IgG-specific bacterial protease IdeS from Streptococcus pyogenes , with improved catalytic efficiency. Biolayer interferometry revealed a fourfold increase in binding affinity relativ...
Topics
Open a Topic to create a Post that cites this publication.
- Antimicrobial Resistance in Staphylococcus
- Bacterial Identification and Susceptibility Testing
- Biochemical and Structural Characterization
- Blood groups and transfusion
- Complement system in diseases
- Monoclonal and Polyclonal Antibodies Research
- Streptococcal Infections and Treatments
- Toxin Mechanisms and Immunotoxins
Identifiers and source
- Literature Corpus work
- a6721f15-fdc8-5fee-aa05-49483a1675ae
- DOI
- 10.64898/2026.06.26.734701
